These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 36646255)

  • 1. Strategic nanocarriers to control neurodegenerative disorders: Concept, challenges, and future perspective.
    Ashique S; Afzal O; Yasmin S; Hussain A; Altamimi MA; Webster TJ; Altamimi ASA
    Int J Pharm; 2023 Feb; 633():122614. PubMed ID: 36646255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug delivery across the blood-brain barrier: recent advances in the use of nanocarriers.
    Mulvihill JJ; Cunnane EM; Ross AM; Duskey JT; Tosi G; Grabrucker AM
    Nanomedicine (Lond); 2020 Jan; 15(2):205-214. PubMed ID: 31916480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanovesicular-Mediated Intranasal Drug Therapy for Neurodegenerative Disease.
    Singh S; Shukla R
    AAPS PharmSciTech; 2023 Sep; 24(7):179. PubMed ID: 37658972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
    Teixeira MI; Lopes CM; Amaral MH; Costa PC
    Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Envisioning the Future of Nanomedicines in Management and Treatment of Neurological Disorders.
    Kumar S; Singh P; Sharma S; Pottoo FH; Ali J; Baboota S
    Comb Chem High Throughput Screen; 2021; 24(10):1544-1556. PubMed ID: 33334281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbon Dots: A Future Blood-Brain Barrier Penetrating Nanomedicine and Drug Nanocarrier.
    Zhang W; Sigdel G; Mintz KJ; Seven ES; Zhou Y; Wang C; Leblanc RM
    Int J Nanomedicine; 2021; 16():5003-5016. PubMed ID: 34326638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the potential role of nano-enabled drug delivery technologies in amyotrophic lateral sclerosis: lessons learned from other neurodegenerative disorders.
    Mazibuko Z; Choonara YE; Kumar P; Du Toit LC; Modi G; Naidoo D; Pillay V
    J Pharm Sci; 2015 Apr; 104(4):1213-29. PubMed ID: 25559087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders.
    Neganova ME; Aleksandrova YR; Sukocheva OA; Klochkov SG
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):805-833. PubMed ID: 35779712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of neurodegenerative disorders through the blood-brain barrier using nanocarriers.
    Poovaiah N; Davoudi Z; Peng H; Schlichtmann B; Mallapragada S; Narasimhan B; Wang Q
    Nanoscale; 2018 Sep; 10(36):16962-16983. PubMed ID: 30182106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics.
    Lamptey RNL; Chaulagain B; Trivedi R; Gothwal A; Layek B; Singh J
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine based strategies for oligonucleotide traversion across the blood-brain barrier.
    Amulya E; Sikder A; Vambhurkar G; Shah S; Khatri DK; Raghuvanshi RS; Singh SB; Srivastava S
    J Control Release; 2023 Feb; 354():554-571. PubMed ID: 36649742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective.
    Nayab DE; Din FU; Ali H; Kausar WA; Urooj S; Zafar M; Khan I; Shabbir K; Khan GM
    J Nanobiotechnology; 2023 Dec; 21(1):477. PubMed ID: 38087359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current advances in the development of novel polymeric nanoparticles for the treatment of neurodegenerative diseases.
    Cano A; Sánchez-López E; Ettcheto M; López-Machado A; Espina M; Souto EB; Galindo R; Camins A; García ML; Turowski P
    Nanomedicine (Lond); 2020 May; 15(12):1239-1261. PubMed ID: 32370600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advancements in Nanocarrier-assisted Brain Delivery of Phytochemicals Against Neurological Diseases.
    Mishra K; Rana R; Tripathi S; Siddiqui S; Yadav PK; Yadav PN; Chourasia MK
    Neurochem Res; 2023 Oct; 48(10):2936-2968. PubMed ID: 37278860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodegenerative disorders management: state-of-art and prospects of nano-biotechnology.
    Kumar R; Aadil KR; Mondal K; Mishra YK; Oupicky D; Ramakrishna S; Kaushik A
    Crit Rev Biotechnol; 2022 Dec; 42(8):1180-1212. PubMed ID: 34823433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders.
    Nguyen TT; Nguyen-Thi PT; Nguyen THA; Ho TT; Tran NM; Van Vo T; Van Vo G
    Mol Diagn Ther; 2023 Jul; 27(4):457-473. PubMed ID: 37217723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Precise are Nanomedicines in Overcoming the Blood-Brain Barrier? A Comprehensive Review of the Literature.
    Mohapatra P; Gopikrishnan M; Doss C GP; Chandrasekaran N
    Int J Nanomedicine; 2024; 19():2441-2467. PubMed ID: 38482521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in nanomedicines for diagnosis of central nervous system disorders.
    Zhang X; Zhou J; Gu Z; Zhang H; Gong Q; Luo K
    Biomaterials; 2021 Feb; 269():120492. PubMed ID: 33153757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances.
    Niu X; Chen J; Gao J
    Asian J Pharm Sci; 2019 Sep; 14(5):480-496. PubMed ID: 32104476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
    Zhao X; Ye Y; Ge S; Sun P; Yu P
    Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.